Advertisement

What Are the Best Management Strategies for Hyperemesis Gravidarum?

  • Lindsey DeGeorge
  • Lauren Wiesner
Chapter

Abstract

Hyperemesis gravidarum (HG) is characterized by unrelenting nausea and vomiting in pregnancy and may be accompanied by weight loss, electrolyte abnormalities, and dehydration. Prompt recognition and early efforts to control symptoms are essential to limiting progression of disease. Fluid and electrolyte repletion, as well as pharmacologic control of symptoms, is the mainstay of acute HG management. Pharmacologic therapy includes dopamine antagonists, selective serotonin inhibitors, and H1 antagonists. For patients with prolonged symptoms, treatment should include supplemental folate and thiamine. Admission is reserved for patients with significant electrolyte abnormalities or severe symptoms refractory to pharmacologic intervention.

Keywords

Hyperemesis gravidarum Vomiting Nausea Pregnancy Dehydration Ondansetron 

References

  1. 1.
    Sheehan P. Hyperemesis gravidarum – assessment and management. Aust Fam Physician. 2007;36(9):698–701.PubMedGoogle Scholar
  2. 2.
    World Health Organization. International classification of diseases: 10. Version: 2010. 2012. http://tinyurl.com/ctcuekp. Accessed 29 June 2016.
  3. 3.
    Kuscu NK, Koyuncu F. Hyperemesis Gravidarum: current concepts and management. Postgrad Med J. 2002;78(916):76–9.CrossRefGoogle Scholar
  4. 4.
    Ismail SK, Kenny L. Review on hyperemesis gravidarum. Clin Gastroenterol. 2007;21(5):755–69.Google Scholar
  5. 5.
    American College of obstetricians and gynecologists practice bulletin summary no. 153. Obstet Gynecol. 2015;126(3):687–8.Google Scholar
  6. 6.
    Matok I, Gorodischer R, Koren G, Sheiner E, Wiznitzer A, Levy A. The safety of metoclopramide use in the first trimester of pregnancy. N Engl J Med. 2009;360(24):2528–35.CrossRefGoogle Scholar
  7. 7.
    Pasternak B, Svanström H, Hvild A. Ondansetron in pregnancy and risk of adverse fetal outcomes. N Engl J Med. 2013;368:814–23. Erratum in N Engl J Med 2013;368:2146.CrossRefGoogle Scholar
  8. 8.
    Danielsson B, Wikner BN, Källén B. Use of ondansetron during pregnancy and congenital malformations in the infant. Reprod Toxicol. 2014;50:134–7.CrossRefGoogle Scholar
  9. 9.
    Abas MN, Tan PC, Azmi N, Omar SZ. Ondansetron compared with metoclopramide for hyperemesis gravidarum: a randomized controlled trial. Obstet Gynecol. 2014;123:1272–9.CrossRefGoogle Scholar
  10. 10.
    Magee LA, Mazzotta P, Koren G. Evidence- based view of safety and effectiveness of pharmacologic therapy for nausea and vomiting of pregnancy (NVP). Am J Obstet Gynecol. 2002;186(5 Suppl Understanding):S256–61. 37.CrossRefGoogle Scholar
  11. 11.
    Fischer-Rasmussen W, Kiaer SK, Dahl C, Asping U. Ginger treatment of hyperemesis gravidarum. Eur J Obstet Gynecol Reprod Biol. 1991;38(1):19–24.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Lindsey DeGeorge
    • 1
  • Lauren Wiesner
    • 2
    • 3
  1. 1.Department of Emergency MedicineMedStar Washington Hospital CenterWashington, DCUSA
  2. 2.Georgetown University School of Medicine, Department of Emergency MedicineWashington, DCUSA
  3. 3.MedStar Washington Hospital CenterWashington, DCUSA

Personalised recommendations